About

Saturday, January 6, 2018

Vitamin K2



Vitamin K2 is an important vitamin especially those with cardiac disease, osteoporosis or MS.
Those supplementing with vitamin D should also be taking vitamin K2 as vitamin D increases the need for vitamin K2.
Most are aware of vitamin K1 which is involved with blood clotting, Newly discovered vitamin K2 is a related molecule with different functions.
Vitamin K2 (menaquinone)
      Directs calcium away from soft tissues such as blood vessels and toward bones and teeth, improving vascular and bone health [1]
      Is essential to building part of the myelin sheath [2], [3]
      Protects myelinating cells and neurons [4], [5]
      Improves overall longevity:

[6-10]


               1.         S. Cockayne, J. Adamson, S. Lanham-New, M.J. Shearer, S. Gilbody and D.J. Torgerson, Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166: 1256-1261
               2.         N.A. Denisova and S.L. Booth, Vitamin K and sphingolipid metabolism: evidence to date. Nutr Rev. 2005; 63: 111-121
               3.         G. Ferland, Vitamin K and the nervous system: an overview of its actions. Adv Nutr. 2012; 3: 204-212
               4.         S.A. Back, N.L. Luo, N.S. Borenstein, J.M. Levine, J.J. Volpe and H.C. Kinney, Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci. 2001; 21: 1302-1312
               5.         J. Li, H. Wang and P.A. Rosenberg, Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J Neurosci Res. 2009; 87: 1997-2005
6         Rees K, Guraewal S, Wong YL, et al. Is vitamin K consumption associated with cardio-metabolic disorders? A systematic review. Maturitas. 2010 Oct;67(2):121-8.
7           Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004 Nov;134(11):3100-5.
8                    Gast GC, de Roos NM, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 19 (2009) 504-510.
9                      Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Nutr. Metab. Cardiovasc. Dis. 19 (2009) 504-510.
10           Vermeer C. Clinical trial on beneficial effects of long term menaquinone-7 (vitamin K2) intake by postmenopausal women. ClinicalTrials.Gov NCT00642551.
Kroon A. The effects of vitamin K2 supplementation on the progression of coronary artery calcification. ClinicalTrials.Gov NCT01002157.


Thursday, December 28, 2017

Cholesterol: the band aids of the body

Some of you might be aware that the FDA recently stated that cholesterol consumption no longer has to be restricted. It turns out they cholesterol along with other molecules “bandage up” injuries along the blood vessel walls caused by inflammation. Cholesterol levels are moreso a marker of inflammation and eating more cholesterol does not raised blood cholesterol levels [16].
In fact cholesterol has some benefits including cell communication, detoxification [17], and even protection of infection and cancers
[1], [2], [3], [4], [5].
Cholesterol is very important for MS as it’s the rate limiting (most important) factor for myelination
[6], [7], [8]. MS also commonly involves underlying chronic infection including Epstein Barr virus [9] [10] [11], candida [12], [13], [14] or bacterial pathogens.
So don’t skimp on the egg yolks, cheese or other A2 dairy
[15].

Personally, I found cholesterol including butter, ghee to be very helpful in giving making me feel better and healing me. Even now that I am a vegetarian, I get plenty of cholesterol from A2 Dairy.   





1.         U. Ravnskov, High cholesterol may protect against infections and atherosclerosis. QJM. 2003; 96: 927-934
2.         M.F. Muldoon, A. Marsland, J.D. Flory, B.S. Rabin, T.L. Whiteside and S.B. Manuck, Immune system differences in men with hypo- or hypercholesterolemia. Clin Immunol Immunopathol. 1997; 84: 145-149
3.         M. Gruber, M. Christ-Crain, D. Stolz, et al., Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study. Swiss Med Wkly. 2009; 139: 166-172
4.         A.A. Alsheikh-Ali, T.A. Trikalinos, D.M. Kent and R.H. Karas, Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol. 2008; 52: 1141-1147
5.         H. Jafri, A.A. Alsheikh-Ali and R.H. Karas, Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol. 2010; 55: 2846-2854
6.         G. Saher, B. Brugger, C. Lappe-Siefke, et al., High cholesterol level is essential for myelin membrane growth. Nat Neurosci. 2005; 8: 468-475
7.         G. Saher, S. Quintes and K.A. Nave, Cholesterol: a novel regulatory role in myelin formation. Neuroscientist. 2011; 17: 79-93
8.         G. Saher and S.K. Stumpf, Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta. 2015; 1851: 1083-1094
9.         A. Ascherio and K.L. Munger, Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007; 61: 288-299
10.       R.A. Farrell, D. Antony, G.R. Wall, et al., Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology. 2009; 73: 32-38
11.       K.L. Munger, L.I. Levin, E.J. O'Reilly, K.I. Falk and A. Ascherio, Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler. 2011; 17: 1185-1193
12.       J. Benito-Leon, D. Pisa, R. Alonso, P. Calleja, M. Diaz-Sanchez and L. Carrasco, Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis. 2010; 29: 1139-1145
13.       D. Pisa, R. Alonso and L. Carrasco, Fungal infection in a patient with multiple sclerosis. Eur J Clin Microbiol Infect Dis. 2011; 30: 1173-1180
14.       D. Pisa, R. Alonso, F.J. Jimenez-Jimenez and L. Carrasco, Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Eur J Clin Microbiol Infect Dis. 2013; 32: 795-801
15.       K. Woodford, Devil in the milk: illness, health and politics of A1 and A2 milk, Chelsea Green Pub (2007).